ClinicalTrials.gg
Status unknownNCT04422483Re-ASCedUpdated May 6, 2021

A Realist Evaluation of Autism ServiCe Delivery (RE-ASCeD)

An observational study in Autism, Children and Family, sponsored by Sussex Community NHS Foundation Trust. Status unknown at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2021-05-06.

Sponsored by Sussex Community NHS Foundation Trust · Observational

How we know

The sponsor has not verified this record recently (last verified May 2021), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Ecologic or community
Time perspective
Retrospective
Enrollment
520
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 37 studies in Autistic Disorder with a site in United Kingdom — 10 open to participants now, 14 under way, none of them phase 3. Autistic Disorder · United Kingdom.

Planned enrollment
4th of 16
520 · median 163
Started
2019
with 1 other
Observational
16 of 37
4 open now
Registered
12th of 37
by date
Lead sponsor
4 of 37
Sussex Community NHS Foundation Trust

Among the 37 studies in Autistic Disorder with a site in United Kingdom, this one is the 4th largest by planned enrollment of the 16 observational ones that give a count, is one of 2 that started in 2019, is one of 16 observational ones, and was the 12th registered.

Autistic Disorder

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

10 of the 37 studies in Autistic Disorder with a site in United Kingdom are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 37 studies in Autistic Disorder with a site in United Kingdom, or all of them as a file.
02

Study summary

Diagnostic pathways for children with possible autism. Which work best, for whom, when, and at what cost? Autism is a complex neuro-behaviour condition. People with autism have difficulty with social interaction and in communication with others. They may struggle with change, and repeat actions over and over. Life may be very anxious or stressful. The signs of autism can occur at any age but often appear in the first two years of life. There is no one type of autism, but many, so the condition is now called autism spectrum disorder (ASD). Autism is lifelong but this study is only about children. Caring for a child with autism can be difficult and can sometimes be tough on the whole family.

This project aims to guide the people who plan services for families and children. Different teams and services that do autism assessments will help us. The investigators will ask teams and services: What speeds up diagnosis? What delays diagnosis?

The study will be in four work packages:

  1. The investigators will review research in the UK and abroad to find evidence and ideas that will help speed up diagnosis.
  2. The investigators will survey professionals who work for the specialist teams who diagnose autism. The survey will be about each step in the process and ask which professionals get involved. The investigators will ask about the number of children they see and the time it usually takes to reach a diagnosis. This will give us a picture of the national situation.
  3. After the national survey, the investigators will select around six or eight teams. These teams will be using different and innovative approaches. The investigators will study those approaches. The investigators will talk to clinical staff, managers, referrers, parents and young people. Parents and young people will have gone through the diagnostic process. The investigators will ask parents and young people about their experiences and views. The investigators will review the steps in the diagnosis process for about 70 children in each service. The investigators will find out how long each assessment takes, how much clinical time it takes, and how much it costs. The investigators will compare findings across teams and services.
  4. The investigators will have national meetings with autism experts and patient groups. The investigators will show them our findings. These groups will agree recommendations for practice. Clinical teams, service managers, commissioners, parents' groups, and NHS England will receive recommendations.

The research team has specialist expertise in autism, health services, economics, and statistics. The team includes public and NHS England partners. This will ensure the investigators take account of the needs of families and the investigators send the findings to people who plan services.

Read the detailed description

Scientific Summary (following Rameses 2 reporting guidelines)

Study Title

A Realist Evaluation of Autism ServiCe Delivery (RE-ASCeD): Which diagnostic pathways work best, for whom, when, and at what cost?

Research Question Which autism diagnostic pathways work best, for whom, in what circumstances, and at what cost when providing timely and high quality diagnostic services?

Secondary Research Questions

  • What factors underpin timely diagnosis service delivery success or failure?
  • What needs to be in place to identify the needs and create individualized, holistic pathways of diagnosis for the child and their family?

Background The NHS England Long Term Plan states: "Children and young people with suspected autism wait too long before being provided with a diagnostic assessment. Over the next three years the investigators aim to test and implement the most effective ways to reduce waiting times...achieving timely diagnostic assessments in line with best practice guidelines...(and) to support children with autism and their families, throughout the diagnostic process." Set against a background of increasing demand for diagnostic assessment, and the need, as recommended by the NICE guidelines, for a multidisciplinary approach to assessment, taking at least 13 hours of professional time and £800 per child, evidence is needed to identify models of diagnostic assessment to achieve timely diagnoses, and how families can best be supported through this process. The NHSE Long Term Plan aims to reduce the wait time for diagnosis, and the aim of this project is to find ways/models to directly address that need.

Aims and Objectives This study aims to examine existing models of Autism diagnostic service delivery, and to investigate which approaches offer the most timely, cost-effective, high quality and child and family friendly solutions, and in line with realist thinking, to identify the factors that are likely to underpin their success, or failure, if rolled out more generally across providers.

Method

The study will use Realist Evaluation methodology, which enables evaluation of complex interventions in health care by building on existing research, to identify "what works, for whom and in what circumstances". Mixed methods, including Rapid Realist (literature) Review, survey of current practice, and case studies of centres delivering promising approaches, will be used to build a picture in an iterative manner, to identify underlying Contexts and Mechanisms that contribute to the desired Outcomes (CMO configurations) of improved Autism diagnostic service delivery and user experience, that in turn can provide plausible explanations of why the service models work or do not in certain circumstances. Data analysis from each phase of the study will be synthesised through a realist evaluative process comprising of four stages:

  1. Articulation of programme theories and propositions from WP1 of the study (rapid realist review). Identification of candidate CMO configurations.
  2. Data collection from WP4 (case studies) of the study to test and refine propositions.
  3. Map the outcomes of each model across the cases; interrogate what contexts and mechanisms explain the pattern of outcomes.
  4. Through stakeholder consolidation (WP5), refine explanatory CMO configurations to evaluate what works best and in what circumstances to deliver timely and cost-effective diagnostic services that meet the needs of children with possible Autism

Initial Programme Theory (Based on NICE principles) If there is an MDT assessment by a team with competencies in child neurodevelopment and mental health (context), then Autism will be recognised as a complex condition that relies on detailed history and observation across settings (mechanism) to diagnose it, leading to an accurate diagnosis, recognition of associated comorbidity such as ADHD and intellectual disability (outcome), and the ruling out of complex differential diagnoses.

This will also create - whilst not an explicit part of this project - accurate pictures of child strengths and needs to inform individualized packages of support and intervention through health, education and social care (outcome).

Work Package One (months 1-7). Rapid Realist Review. Evidence will be sought from published studies and evaluations of Autism diagnostic services, including controlled trials, uncontrolled studies, cost-effectiveness studies, process evaluations, grey literature and qualitative studies, including unpublished information about locally implemented Autism services. The purpose will be to refine or develop initial programme theories.

Work Package Two (months 1-6): National/International Survey of Current Diagnostic Practice: An electronic survey will be sent to UK CDCs, CAMHS teams, and tertiary centres, delivering Autism diagnostic services. This will ask teams to describe current challenges to, and any new models of diagnostic service delivery they are using. Analysis will use both qualitative and quantitative methods, to identify common themes, and services using novel approaches.

Work Package Three (months 7-9): Purposive Sampling Frame. The findings of WP 1 \& 2 will be used to develop a matrix of the key features of service delivery, plus other contextual factors such as lower SES, rural, urban etc. This will be used as a sampling frame. It is anticipated that 6-8 service delivery models will be purposefully selected as case studies across the matrix to ensure the investigators have a full range of delivery models and population characteristics.

Work Package Four: Case studies (months 10-29): In-depth exploration of individual service models will be carried out to determine the interrelationship of context, intervention, mechanisms and outcomes as they occur in their natural setting. Data will be gathered within case studies using mixed methods at two levels: (i) service model and (ii) individual child/ family. Methods will include semi structured realist Interviews, focus groups, and document reviews to assemble a comprehensive description of the service and model. Interviewees will include commissioners, service managers, clinicians, referrers, parents and young people. Interviews will be recorded and transcribed, proceeding to qualitative analysis based on components of the programme theory. Regular team meetings will discuss coding, address inconsistencies, and refine collective understanding of coding framework. Coded data will be collated using NVivo software.

For each case study the journeys of at last 58 children completing the diagnostic pathway will be recorded from case notes to measure pathway, hours of professional input and time to diagnosis. Costs incurred by families for example travel to clinic, loss of earnings, will be collected by interview. Associations between service use costs and characteristics of the child and model will be assessed by regression analysis.

Work Package Five: Consolidation event, Months 27-28 : The investigators will run two iterative national consensus workshops, inviting key stakeholders including NHSE and parents/young people, to refine and confirm the context-mechanism-outcome configurations, and salient actions required to deliver timely, reliable and costed diagnostic services that meet the needs of children with possible Autism. This will lead to dissemination of models to inform the ongoing development of service models within the NHSE Long-Term Plan, commissioning guidelines and local service development.

03

Conditions studied

  • Autism
  • Children
  • Family
  • Diagnoses, Syndromes, and Conditions
  • Patient Satisfaction
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Members of staff. referrers, and users of Autism diagnostic services for children.

Eligibility criteria

Survey Inclusion Criteria:

  • Lead clinicians for childhood autism diagnostic assessment teams (children age 1-18 years), or someone who they nominate.

Survey Exclusion Criteria:

  • Members of staff not involved in Autism diagnostic services.

Case Studies Inclusion Criteria :

  • Parents of young people who have been through the diagnostic pathway
  • Young people who have been through the diagnostic pathways
  • Clinicians working in centres involved in the autism diagnostic process
  • Commissioners and managers of autism services; professionals who refer in to the autism pathways

Case Studies Exclusion Criteria:

  • Adults on the autism pathway
  • Professionals involved in the adult autism pathway
05

Study design

Observational model
Ecologic or community
Time perspective
Retrospective
Enrollment
520 participants (estimated)
Patient registry
No

Groups and cohorts

  • Service Model Level Case Studies

    Realist Interviews. MONTHS 9-30 (N=6-8 sites, 12 people per site, 96 interviewees)

    Other: Realist evaluation

  • Individual/family level interviews

    Child Interviews. MONTHS 9-30 (N=6-8 sites, 6 people per site, max. 48 interviewees)

    Other: Realist evaluation

  • Individual child/family Level Case Studies:

    MONTHS 10-30 (N=6-8 sites, 78 people per model (x4), 312 participants, 156 per NU/SCFT depending on distribution of sites)

    Other: Realist evaluation

  • Focus groups:

    MONTHS 9-30 (N=6-8 sites, 6-8 focus groups of up to 8 parents) N= 64

    Other: Realist evaluation

Interventions

  • OtherRealist evaluation

    In-depth exploration of individual service models will be carried out to determine the interrelationship of context, intervention, mechanisms and outcomes as they occur in their natural setting. Data will be gathered within case studies using mixed methods at two levels: (i) service model and (ii) individual child/ family. Methods will include semi structured realist Interviews, focus groups, and document reviews to assemble a comprehensive description of the service and model. Interviewees will include commissioners, service managers, clinicians, referrers, parents and young people. Interviews will be recorded and transcribed, proceeding to qualitative analysis based on components of the programme theory. Regular team meetings will discuss coding, address inconsistencies, and refine collective understanding of coding framework. Coded data will be collated using NVivo software.

    Also known as: focus group, health economic questionnaire, survey, Interview, Case note data

06

What researchers measure

Primary outcomes

  1. Case Study: Case Note Review - Pathway completion time taken

    Research team monitor steps in the diagnostic pathway. Access child's clinical care records for pathway completion: Time taken from referral to diagnosis/discharge (in days).

    Time frame: Up to 24 months

Secondary outcomes

  1. Questionnaire: Reported Challenges

    National/International Survey of Current Diagnostic Practice: Asking diagnostic service teams to describe current challenges to, and any new models of diagnostic service delivery they are using.

    Time frame: Up to 6 months

  2. Questionnaire: Reported Type of Service

    National/International Survey of Current Diagnostic Practice: Asking diagnostic service teams to describe type of service, e.g. Child Adolescent Mental Health Services, Child Development Clinic, Tertiary referral, in-patient ward, finance department.

    Time frame: Up to 6 months

  3. Questionnaire: Reported New Models of Services

    National/International Survey of Current Diagnostic Practice: Asking diagnostic service teams to describe any new models of diagnostic service delivery they are using.

    Time frame: Up to 6 months

  4. Questionnaire: Reported Geographical Area

    National/International Survey of Current Diagnostic Practice: Asking diagnostic service teams to describe Geographical area (England), e.g. population size, ethnic background, socioeconomic status.

    Time frame: Up to 6 months

  5. Questionnaire: Reported Activity Levels

    National/International Survey of Current Diagnostic Practice: Asking diagnostic service teams to describe Activity levels: - Numbers of new referrals into and out of the service annually Number on current case-loads Waiting list times e.g. average Number of diagnoses (different types) per year Time taken to reach diagnosis

    Time frame: Up to 6 months

  6. Questionnaire: Reported Resources Available

    National/International Survey of Current Diagnostic Practice: Asking diagnostic service teams to describe resources available:- Team size Team composition Professional multidisciplinary skill mix Facilities available Equipment available

    Time frame: Up to 6 months

  7. Questionnaire: Reported Age Range of Service

    National/International Survey of Current Diagnostic Practice: Asking diagnostic service teams to describe reported age range of services

    Time frame: Up to 6 months

  8. Questionnaire: Reported Clinical Remit

    National/International Survey of Current Diagnostic Practice: Asking diagnostic service teams to describe services remit and confirm type of service assessments for children for:- Autism ADHD Early trauma Neuro-disability Mental health, Common comorbidities Differential diagnoses of Autism

    Time frame: Up to 6 months

  9. Questionnaire: Reported Clinical Team Competencies for Clinical Remit

    National/International Survey of Current Diagnostic Practice: Asking diagnostic service teams to describe services remit and confirm professional service competencies for children for:- Autism ADHD Early trauma Neuro-disability Mental health, Common comorbidities Differential diagnoses of Autism

    Time frame: Up to 6 months

  10. Case Study - Diagnostic Team Realist Interviews

    Realist interviews either with between 6 and 12 team members per service to include commissioners, managers, clinicians, and referrers (GPs, SENCOs, HV, School nurse).

    Time frame: 1 hour interview during 12 month case studies

  11. Case Study: Child and Family Interviews

    Convenience sample of children and families who have recently been referred for assessment and diagnosis.

    Time frame: 30 minutes interview during 12 month case studies

  12. Case Study: Case Note Review - Dates of Meetings

    Research team monitor steps in the diagnostic pathway. Access child's clinical care records for dates of meetings to construct timeline.

    Time frame: Up to 20 months

  13. Case Study: Case Note Review - Duration of Meetings

    Research team monitor steps in the diagnostic pathway. Access child's clinical care records for duration of meetings to calculate time taken overall to complete pathway.

    Time frame: Up to 20 months

  14. Case Study: Case Note Review - Purpose of Clinical Meeting

    Research team monitor steps in the diagnostic pathway. Access child's clinical care records for purpose of contact with family/child for health professionals.

    Time frame: Up to 20 months

  15. Case Study: Case Note Review - Test results

    Research team monitor steps in the diagnostic pathway. Access child's clinical care records for test results .

    Time frame: Up to 20 months

  16. Case Study: Case Note Review Pathway completion final diagnosis

    Research team monitor steps in the diagnostic pathway. Access child's clinical care records for final diagnosis.

    Time frame: Up to 20 months

  17. Case Study: Case Note Review - Pathway completion time taken

    Research team monitor steps in the diagnostic pathway. Access child's clinical care records for pathway completion: Time taken from referral to diagnosis/discharge (in days).

    Time frame: Up to 20 months

  18. Case Study: Case Note Review Pathway Completion Co-Morbidities

    Research team monitor steps in the diagnostic pathway. Access child's clinical care records for any co-morbidities.

    Time frame: Up to 20 months

  19. Case Study: Case Note Review Pathway Completion- type of professional involved

    Research team monitor steps in the diagnostic pathway. Access child's clinical care records for type of professionals involved.

    Time frame: Up to 20 months

Other outcomes

  1. Realist Evaluation Outcomes

    Reported Outcomes of Autism diagnostic service delivery and user experience, that provide plausible explanations of why the service models work or do not in certain circumstances.

    Time frame: Up to 32 months

  2. Realist Evaluation Contexts

    Reported Contexts of Autism diagnostic service delivery and user experience, that provide plausible explanations of why the service models work or do not in certain circumstances.

    Time frame: Up to 32 months

  3. Realist Evaluation Mechanisms

    Reported Mechanisms of Autism diagnostic service delivery and user experience, that provide plausible explanations of why the service models work or do not in certain circumstances.

    Time frame: Up to 32 months

  4. Rapid Realist Review

    Rapid Realist Review (RRR) will build on the systematic review undertaken in preparation of the NICE guidelines. The RRR will add to this through providing context-specific explanations for what works within a particular set of parameters. RRR is a well-established approach to synthesising evidence within a compressed time period that can identify groups of interventions or models of service delivery that relate to desired outcomes. It is also seen as consistent with the RAMESES standards for realist syntheses.

    Time frame: Up to 7 months

  5. Novel Health Economic Evaluation Questionnaire: Parent Reported Experience

    Parents reported experience of the diagnostic process up to either diagnosis or discharge. Maximum values will be unknown until data set is complete. Reports from parents may be either positive or negative and will be on a Likert scale of 1-10 with 1 strong against the current diagnostic process and 10 strongly in favour.

    Time frame: Every 3 months from the date of participant consent and assessed up to a maximum of 24 months

  6. Novel Health Economic Evaluation Questionnaire: Parent Reported Expenses

    Parents reported out of pocket expenses on travel, loss of earnings, childcare costs. Values will be in pound sterling and maximum will be unknown until data set is complete.

    Time frame: Every 3 months from the date of participant consent and assessed up to a maximum of 24 months

07

Study locations

1 of 1 sites recruiting
  • Nightingale Primary Care Centre
    Haywards Heath, West Sussex RH16 4BN, United Kingdom
    Recruiting
08

References and documents

Publications

  • Abrahamson V, Zhang W, Wilson PM, Farr W, Reddy V, Parr J, Peckham A, Male I. Realist evaluation of Autism ServiCe Delivery (RE-ASCeD): which diagnostic pathways work best, for whom and in what context? Findings from a rapid realist review. BMJ Open. 2021 Dec 14;11(12):e051241. doi: 10.1136/bmjopen-2021-051241. PubMed 34907053 ↗
  • Abrahamson V, Zhang W, Wilson P, Farr W, Male I. Realist Evaluation of Autism ServiCe Delivery (RE-ASCeD): which diagnostic pathways work best, for whom and in what context? Protocol for a rapid realist review. BMJ Open. 2020 Jul 6;10(7):e037846. doi: 10.1136/bmjopen-2020-037846. PubMed 32636288 ↗

Individual participant data

Plan to share: Yes — IPD data that is anonymised, will be released by the project steering commitee,and only then, IPD data that underlie results in publication will be shared

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Starting September 2023

Access criteria: Anonymised IPD will be shared if the applicant writes to the project steering committee who will review the request. Access will only be allowed once the study is complete and all publications are complete.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2019 (actual). Primary completion is estimated for Jun 2022, 31 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 18, 2020
First posted
Jun 9, 2020
StartActual
Nov 30, 2019
Primary completionEst.
Jun 30, 2022
CompletionEst.
Dec 30, 2022
Last update
May 6, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 6, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04422483
Lead sponsor
Sussex Community NHS Foundation Trust
Collaborators
University of Kent, University of Surrey, Newcastle University, Council for Disabled Children, Autistica, West Sussex Parent Carer Forum, Northumberland, Tyne and Wear NHS Foundation Trust, Cambridgeshire and Peterborough NHS Foundation Trust, Brighton & Sussex Medical School, National Health Service, United Kingdom
Responsible party
William Farr (Principal Investigator, Sussex Community NHS Foundation Trust) — Principal investigator
First posted
Jun 9, 2020
Start date
Nov 30, 2019
Primary completion
Jun 30, 2022 (estimated)
Completion
Dec 30, 2022 (estimated)
Last update
May 6, 2021

Study contacts

Will Senior Research Fellow, PhD
Contact
will.farr@nhs.net
UK 01444 475804
Helen Vaughan
Contact
helenvaughan@nhs.net
01273 696011
Ian Male, Msc MRCP MBBCh
principal investigator · Sussex Community NHS Foundation Trust

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion